Chimpharm provides to KASE extract from shareholders registers system as of July 1, 2017

/KASE, July 14, 2017/ – Chimpharm (Shymkent, hereinafter – the company), shares of which are officially listed on Kazakhstan Stock Exchange (KASE), has provided to KASE an extract from its shareholders registers system as of July 1, 2017. According to the mentioned extract: - the total number of authorized common shares KZ1C20620015 of the company makes up 10,025,004 units, preferred shares KZ1P20620418 - 131,945 units; - 8,620,140 common shares and all preferred shares of the company are outstanding; - the sole company's shareholder and the only person holding five or more percent of total outstanding shares of the company is CENTRAL ASIA PHARMA HOLDING B.V. (Delft, Netherlands), who owns 8,650,332 shares of the company (98.84% of the total number of the outstanding shares of the company), including 8,555,917 common shares (99.25% of the total number of the outstanding shares of the company) and 94,415 preferred shares of the company (71.56% of the total number of the outstanding shares of the company). [2017-07-14]